In 2025, the Hospital Regional do Baixo Amazonas (HRBA) in Santarém, western Pará, reported that 74% of childhood cancer diagnoses were attributed to leukemia, specifically affecting white blood cells and bone marrow. The facility recorded a total of 144 children treated in its pediatric oncology department, with lymphomas accounting for 15% of cases and neuroblastoma for 4%. These statistics highlight the pressing issue of childhood leukemia in this region and the health challenges it poses for young patients and their families.

The hospital provided further details, indicating that 26% of children diagnosed did not have cancer after medical investigation, suggesting the importance of accurate diagnosis in pediatric oncology. Meanwhile, 48% of the patients remain under clinical monitoring, 22% are currently undergoing active cancer treatment, and 4% are in the staging phase to assess the extent of the disease in their bodies. This emphasis on comprehensive care and monitoring reflects a proactive approach to addressing childhood cancer.

These findings align with the broader epidemiological profile of pediatric oncology at HRBA, which shows a notable prevalence of hematological conditions among its patients. Understanding these trends is crucial for developing targeted interventions and improving treatment protocols for childhood cancer in the region, ultimately aiming to enhance patient outcomes and offer better support for affected families.